home / stock / prct / prct news


PRCT News and Press, PROCEPT BioRobotics Corporation

Stock Information

Company Name: PROCEPT BioRobotics Corporation
Stock Symbol: PRCT
Market: NASDAQ
Website: procept-biorobotics.com

Menu

Get PRCT Alerts

News, Short Squeeze, Breakout and More Instantly...

PRCT - PRCT Price Target Alert: $25.00. Issued by Truist Financial

2026-07-02 18:15:03 ET from Truist Financial issued a price target of $25.00 for PRCT on 2026-07-02 20:06:25. The adjusted price target was set to $25.00. At the time of the announcement, PRCT was trading at $21.03. The overall price target consensus is at $31.60 with hi...

PRCT - Hold Recommendation Issued On PRCT By Citigroup

2026-07-02 17:15:03 ET Citigroup analyst issues HOLD recommendation for PRCT on July 2, 2026 08:06PM ET. PRCT was trading at $21.03 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 10 - Buy, 4 - Hold, 1 - ...

PRCT - 10 small-cap U.S. healthcare stocks with the weakest momentum grades

2026-06-24 10:20:43 ET More on healthcare stocks IXJ: Healthcare Sector Dashboard For June IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action AI Revolutionizing Biopharma: Faster, Better, Cheaper 10 small-cap U.S. healthcare stocks wi...

PRCT - Outperform Recommendation Issued On PRCT By Evercore ISI

2026-06-24 07:15:09 ET Evercore ISI analyst issues OUTPERFORM recommendation for PRCT on June 24, 2026 10:05AM ET. PRCT was trading at $20.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 10 - Buy, 4 - H...

PRCT - PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks

2026-06-11 11:11:31 ET Shares of PROCEPT BioRobotics ( PRCT ) fell 8% on Thursday after Leerink Partnerscdowngraded the stock to Market Perform from Outperform and lowered its price target to $29 from $31, citing growing competitive risks and reduced confidence in the company's near...

PRCT - PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the randomized WATER IV study evaluating Aquablation® therapy versus radical prostatectomy, and F...

PRCT - AUA Guidelines Strengthen Recommendation for Aquablation® Therapy

SAN JOSE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) today highlighted the latest update to the American Urological Association (AUA) Guidelines for the management of lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), which...

PRCT - PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

2026-05-12 20:40:45 ET PROCEPT BioRobotics Corporation (PRCT) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT... Read the full article on Seeking Alpha For further details see: PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Glob...

PRCT - PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at three ...

PRCT - Procept (PRCT) Q1 2026 Earnings Transcript

2026-04-30 12:23:49 ET Image source: The Motley Fool. Wednesday, April 29, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

Next 10